iShares Global Healthcare ETF (IXJ)
111.16
-0.21 -0.19%
NYSE Arca
Jun 23, 16:59
Delayed 2m
USD
IXJ Key Stats
| Expense Ratio | 0.48% |
| Share Class Assets Under Management | 1.597B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 111.35 |
| Discount or Premium to NAV | 0.02% |
| Turnover Ratio | 5.00 |
View All IXJ News
IXJ News
-
WireHeadlineTime (ET)
-
SA Breaking News06/22 15:13
-
SA Breaking News06/22 11:24
-
SA Breaking News06/22 10:04
-
Yahoo06/22 07:36
-
SA Breaking News06/20 14:53
-
Yahoo06/05 10:36
-
Yahoo05/31 07:36
-
Yahoo05/30 17:05
-
Yahoo05/29 14:05
-
SA Breaking News05/26 10:33
IXJ Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | 5.68% | 7.37% | 87 |
| 3M | 9.45% | 9.80% | 67 |
| 6M | 18.99% | 20.75% | 58 |
| 1Y | 14.23% | 21.09% | 85 |
| 3Y | 7.78% | 9.79% | 80 |
| 5Y | 15.79% | 18.20% | 81 |
Returns for periods of 1 year and above are annualized.
IXJ Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.43% | 0.57% | 0.14% |
| Stock | 99.57% | 99.57% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | -0.00% | 0.00 | 0.00% |
IXJ Region Exposure
| Americas | 69.68% |
| North America | 69.68% |
| Latin America | 0.00 |
| Greater Europe | 23.88% |
| United Kingdom | 4.66% |
| Europe Developed | 19.23% |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 6.43% |
| Japan | 4.87% |
| Australasia | 1.56% |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00 |
Region breakdown data is calculated by using the long position holdings of the portfolio.
IXJ Stock Sector Exposure
| Basic Materials | 0.36% |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 98.75% |
| Industrials | 0.00 |
| Real Estate | 0.00 |
| Technology | 0.89% |
| Utilities | 0.00 |
IXJ Stock Market Capitalization
| Giant | 57.44% |
| Large | 36.22% |
| Medium | 6.15% |
| Small | 0.19% |
| Micro | 0.00 |
IXJ Stock Style Exposure
| Large Cap Value | 24.48% |
| Large Cap Blend | 38.17% |
| Large Cap Growth | 31.02% |
| Mid Cap Value | 1.36% |
| Mid Cap Blend | 2.12% |
| Mid Cap Growth | 2.67% |
| Small Cap Value | 0.00 |
| Small Cap Blend | 0.19% |
| Small Cap Growth | 0.00 |
View More Holdings
As of June 22, 2017
IXJ Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.11% | 136.38 | +0.24% |
| NVSEF | Novartis AG | 5.01% | -- | -- |
| PFE | Pfizer Inc | 4.50% | 34.09 | +0.09% |
| RHHVF | Roche Holding AG Dividend Right Cert. | 4.05% | -- | -- |
| MRK | Merck & Co Inc | 4.00% | 66.06 | +0.06% |
| UNH | UnitedHealth Group Inc | 3.98% | 185.18 | -0.71% |
| AMGN | Amgen Inc | 2.83% | 172.67 | -0.66% |
| MDT | Medtronic PLC | 2.70% | 89.19 | +0.11% |
| ABBV | AbbVie Inc | 2.58% | 72.64 | -0.74% |
| SNYNF | Sanofi SA | 2.51% | -- | -- |
Advertisement
IXJ Ratings
| Fiduciary Score | Upgrade |
IXJ One Page Reports
- One Page Report Download
IXJ Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Benchmark Index | |
|---|---|
S&P Global 1200 Healthcare Sector NR USD |
100.0% |
IXJ Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 1.13 yrs |
| Diane Hsiung | 9.42 yrs |
| Greg Savage | 9.42 yrs |
| Jennifer Hsui | 4.83 yrs |
IXJ Net Fund Flows
| 1M | -15.90M |
| 3M | -26.38M |
| 6M | -2.539M |
| YTD | -11.88M |
| 1Y | -138.75M |
| 3Y | 167.40M |
| 5Y | 408.07M |
| 10Y | 235.77M |
IXJ Risk Info
| Beta (5Y) | 0.9257 |
| Max Drawdown (All) | 42.81% |
| Historical Sharpe (10Y) | 0.6124 |
| Historical Sortino (All) | 0.669 |
| 30-Day Rolling Volatility | 7.66% |
| Daily Value at Risk (VaR) 1% (All) | 3.00% |
| Monthly Value at Risk (VaR) 1% (All) | 11.79% |
IXJ Fundamentals
| Dividend Yield TTM (6-23-17) | 1.54% |
| SEC Yield (12-31-15) | 1.42% |
| Weighted Average PE Ratio | 23.87 |
| Weighted Average Price to Sales Ratio | 2.089 |
| Weighted Average Price to Book Ratio | 3.662 |
| Weighted Median ROE | 23.56% |
| Weighted Median ROA | 8.44% |
| Forecasted Dividend Yield | 2.13% |
| Forecasted PE Ratio | 20.35 |
| Forecasted Price to Sales Ratio | 1.944 |
| Forecasted Price to Book Ratio | 3.251 |
| Number of Holdings | 112 |
IXJ Growth Estimates
| Forecasted 5 Yr Earnings Growth | 8.89% |
| Forecasted Book Value Growth | 7.36% |
| Forecasted Cash Flow Growth | 9.37% |
| Forecasted Earnings Growth | 5.97% |
| Forecasted Revenue Growth | 8.64% |
IXJ Comparables
EditIXJ Attributes
| Key Dates | |
|---|---|
| Inception Date | 11/13/2001 |
| Last Annual Report Date | 3/31/2017 |
| Last Prospectus Date | 8/1/2016 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
IXJ Excel Add-In Codes
- Name: =YCI("IXJ","name")
- Broad Asset Class: =YCI("IXJ", "broad_asset_class")
- Broad Category: =YCI("IXJ", "broad_category_group")
- Prospectus Objective: =YCI("IXJ", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
